Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists - PubMed (original) (raw)

Comparative Study

. 1988 Aug 5;241(4866):701-3.

doi: 10.1126/science.2899909.

Affiliations

• PMID: 2899909
• DOI: 10.1126/science.2899909

Comparative Study

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists

T Honoré et al. Science. 1988.

Abstract

The N-methyl-D-aspartate (NMDA)-subtype of glutamate receptors has been well described as a result of the early appearance of NMDA antagonists, but no potent antagonist for the "non-NMDA" glutamate receptors has been available. Quinoxalinediones have now been found to be potent and competitive antagonists at non-NMDA glutamate receptors. These compounds will be useful in the determination of the structure-activity relations of quisqualate and kainate receptors and the role of such receptors in synaptic transmission in the mammalian brain.

PubMed Disclaimer

Similar articles

• Excitatory amino acid receptor mediation of sensory inputs to functionally identified dorsal horn neurons in cat spinal cord.
  Radhakrishnan V, Henry JL. Radhakrishnan V, et al. Neuroscience. 1993 Jul;55(2):531-44. doi: 10.1016/0306-4522(93)90522-h. Neuroscience. 1993. PMID: 7690912
• Beta-N-oxalylamino-L-alanine action on glutamate receptors.
  Ross SM, Roy DN, Spencer PS. Ross SM, et al. J Neurochem. 1989 Sep;53(3):710-5. doi: 10.1111/j.1471-4159.1989.tb11762.x. J Neurochem. 1989. PMID: 2547898
• Quinoxalinediones as excitatory amino acid antagonists in the vertebrate central nervous system.
  Davies SN, Collingridge GL. Davies SN, et al. Int Rev Neurobiol. 1990;32:281-303. doi: 10.1016/s0074-7742(08)60586-3. Int Rev Neurobiol. 1990. PMID: 1981885 Review. No abstract available.
• Receptors for the excitatory amino acids in the mammalian central nervous system.
  McLennan H. McLennan H. Prog Neurobiol. 1983;20(3-4):251-71. doi: 10.1016/0301-0082(83)90004-7. Prog Neurobiol. 1983. PMID: 6142499 Review.

Cited by

• Cochlear kainate receptors.
  Peppi M, Landa M, Sewell WF. Peppi M, et al. J Assoc Res Otolaryngol. 2012 Apr;13(2):199-208. doi: 10.1007/s10162-011-0309-9. Epub 2012 Jan 10. J Assoc Res Otolaryngol. 2012. PMID: 22231646 Free PMC article.
• Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis.
  Cisternas P, Salazar P, Silva-Álvarez C, Barros LF, Inestrosa NC. Cisternas P, et al. J Biol Chem. 2016 Dec 9;291(50):25950-25964. doi: 10.1074/jbc.M116.735373. Epub 2016 Oct 4. J Biol Chem. 2016. PMID: 27703002 Free PMC article.
• Progesterone directly and rapidly inhibits GnRH neuronal activity via progesterone receptor membrane component 1.
  Bashour NM, Wray S. Bashour NM, et al. Endocrinology. 2012 Sep;153(9):4457-69. doi: 10.1210/en.2012-1122. Epub 2012 Jul 20. Endocrinology. 2012. PMID: 22822163 Free PMC article.
• 2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin.
  Rosenberg PA, Loring R, Xie Y, Zaleskas V, Aizenman E. Rosenberg PA, et al. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4865-9. doi: 10.1073/pnas.88.11.4865. Proc Natl Acad Sci U S A. 1991. PMID: 1675790 Free PMC article.
• Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture.
  Pérez A, Probert AW, Wang KK, Sharmeen L. Pérez A, et al. J Neurovirol. 2001 Feb;7(1):1-10. doi: 10.1080/135502801300069575. J Neurovirol. 2001. PMID: 11519477

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database